Mark A. Atkinson mostly deals with Immunology, Type 1 diabetes, Diabetes mellitus, Internal medicine and Endocrinology. His study involves Autoimmunity, Autoantibody, Immune system, Autoimmune disease and Antigen, a branch of Immunology. His study explores the link between Type 1 diabetes and topics such as Disease that cross with problems in Natural history and Developmental psychology.
He combines subjects such as Surgery and Intensive care medicine with his study of Diabetes mellitus. The study incorporates disciplines such as Nephropathy and Oncology in addition to Internal medicine. His Endocrinology research includes elements of Antibody, IL-2 receptor and Cytokine.
Mark A. Atkinson mainly focuses on Type 1 diabetes, Immunology, Diabetes mellitus, Internal medicine and Endocrinology. His research in Type 1 diabetes focuses on subjects like Disease, which are connected to Natural history. His work in Immunology addresses issues such as Islet, which are connected to fields such as Transplantation.
As a part of the same scientific study, Mark A. Atkinson usually deals with the Diabetes mellitus, concentrating on Intensive care medicine and frequently concerns with Clinical trial. His research in Endocrinology intersects with topics in Antibody, Cytokine and Insulin dependent diabetes. His studies deal with areas such as Adoptive cell transfer and Insulitis as well as NOD mice.
His primary areas of study are Type 1 diabetes, Diabetes mellitus, Internal medicine, Pancreas and Islet. His work deals with themes such as Autoantibody, C-peptide, Immunology and Autoimmunity, Disease, which intersect with Type 1 diabetes. Mark A. Atkinson is studying Antigen, which is a component of Immunology.
The Diabetes mellitus study combines topics in areas such as Intensive care medicine, MEDLINE and Pathology. He has included themes like Gastroenterology and Endocrinology in his Internal medicine study. His Islet study also includes fields such as
Type 1 diabetes, Diabetes mellitus, Autoimmunity, Disease and Immune system are his primary areas of study. His research investigates the link between Type 1 diabetes and topics such as Type 2 diabetes that cross with problems in Obesity. He has researched Diabetes mellitus in several fields, including Pancreas, Internal medicine, Pathogenesis, Pathology and Endocrine system.
His Internal medicine study incorporates themes from SNP, Autoantibody and Endocrinology. His Autoimmunity study is concerned with the larger field of Immunology. His study in Immunology is interdisciplinary in nature, drawing from both Microbiome and Genotype, Haplotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Type 1 Diabetes
Mark A Atkinson;George S Eisenbarth;Aaron W Michels.
The Lancet (2014)
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Mark A Atkinson;George S Eisenbarth.
The Lancet (2001)
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Mark A. Atkinson;Noel K. Maclaren.
The New England Journal of Medicine (1994)
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
Daniel L. Kaufman;Michael Clare-Salzler;Jide Tian;Thomas Forsthuber.
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
S. Brian Wilson;Sally C. Kent;Kurt T. Patton;Tihamer Orban.
Toward defining the autoimmune microbiome for type 1 diabetes
Adriana Giongo;Kelsey A. Gano;David B. Crabb;Nabanita Mukherjee.
The ISME Journal (2011)
The NOD mouse model of type 1 diabetes: As good as it gets?
Mark A. Atkinson;Edward H. Leiter.
Nature Medicine (1999)
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
Matthew J Delano;Philip O. Scumpia;Jason S. Weinstein;Dominique Coco.
Journal of Experimental Medicine (2007)
Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Christopher T. Brown;Austin G. Davis-Richardson;Adriana Giongo;Kelsey A. Gano.
PLOS ONE (2011)
Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
D L Kaufman;M G Erlander;M Clare-Salzler;M A Atkinson.
Journal of Clinical Investigation (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: